MILESTONE SCIENTIFIC INC. Segments Disclosure

NOTE L — SEGMENT AND GEOGRAPHIC DATA

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (the “CODM”). The Company conducts its business through two reportable segments: Dental and Medical. These segments offer different products and services to different customer base. The CODM assesses the financial performance of the segment and decides how to allocate resources based on Product sales, net, and Operating income (loss). The Company provides general corporate services to its segments; however, these services are not considered when making operating decisions and assessing segment performance. These services are reported under “Corporate Services” below and these include costs associated with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities and public company compliance. Certain reclassifications have been made to the 2025 consolidated financial statements to conform to the 2024 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously reported.

 

The following tables present information about our reportable and operating segments:

 SCHEDULE OF REPORTABLE AND OPERATING SEGMENTS

Product sales, net

Corporate

Dental

Medical

Total

		2025
		Corporate				Dental				Medical				Total
Product sales, net		$	-			$	8,790,732			$	183,250			$	8,973,982
Cost of products sold			-				2,563,613				2,792				2,566,405
Gross Margin			-				6,227,119				180,458				6,407,577
															-
Salaries & employee benefits			692,808				1,677,601				718,192				3,088,601
Stock Compensation			1,579,504				-				-				1,579,504
Royalty expense			-				435,799				9,283				445,082
Warehouse			11,818				458,537				44,906				515,261
Quality and Regulatory			221,775				102,818				11,831				336,424
Marketing			67,870				195,698				61,165				324,733
Rent & occupancy costs			75,377				51,416				32,135				158,928
Consultants and professional services fees			2,892,406				222,486				463,338				3,578,230
Insurance			165,487				184,928				162,830				513,245
Travel Expense			94,383				71,473				74,470				240,326
Depreciation and amortization expense			78,195				-				-				78,195
Research and development expense			-				430,676				18,793				449,469
Other segment items			308,386				472,422				15,388				796,196
Total operating expenses			6,188,009				4,303,854				1,612,331				12,104,194
Operating income (loss)			(6,188,009	)			1,923,265				(1,431,873	)			(5,696,617	)

 

Product sales, net			Corporate				Dental				Medical				Total
		2024
		Corporate				Dental				Medical				Total
Product sales, net		$	-			$	8,525,308			$	104,620			$	8,629,928
Cost of products sold			-				2,186,142				9,198				2,195,340
Gross Margin			-				6,339,166				95,422				6,434,588
Salaries & employee benefits			1,353,193				1,559,933				828,269				3,741,395
Stock Compensation			1,343,044				-				2,078				1,345,122
Royalty expense			-				436,828				5,231				442,059
Warehouse			14,589				448,190				34,058				496,837
Quality and Regulatory			441,892				24,614				16,359				482,865
Marketing			31,526				439,830				89,539				560,895
Rent & occupancy costs			74,847				48,973				30,608				154,428
Consultants and professional services fees			2,284,403				252,136				818,052				3,354,591
Insurance			178,185				203,648				189,343				571,176
Travel Expense			65,773				98,334				95,348				259,455
Depreciation and amortization expense			37,448				-				-				37,448
Research and development expense			-				835,851				22,916				858,767
Other segment items			450,349				416,587				19,571				886,507
Total operating expenses			6,275,249				4,764,924				2,151,372				13,191,545
Operating income (loss)			(6,275,249	)			1,574,242				(2,055,950	)			(6,756,957	)

 

 

December 31, 2025
		Dental				Medical				Corporate				Total
Total Assets		$	5,861,323			$	394,267			$	1,550,839			$	7,806,429
			5,861,323				394,267				1,550,839				7,806,429

 

December 31, 2024
		Dental				Medical				Corporate				Total
Total Assets		$	5,359,734			$	444,513			$	3,992,825			$	9,797,072
			5,359,734				444,513				3,992,825				9,797,072

 

The following table presents information about our operations by geographic area as of December 31, 2025 and 2024. Net sales by geographic area are based on the respective locations of our subsidiaries.

 SCHEDULE OF SALES BY PRODUCT AND BY GEOGRAPHICAL REGION

		Year Ended December 31, 2025												Year Ended December 31, 2024
		Dental				Medical				Grand Total				Dental				Medical				Grand Total
Domestic-US
Instruments		$	652,044			$	18,400			$	670,444			$	653,990			$	4,000			$	657,990
Handpieces			4,105,727				150,850				4,256,577				4,489,521				57,700				4,547,221
Other			42,194				-				42,194				49,120								49,120
Grand Total		$	4,799,965			$	169,250			$	4,969,215			$	5,192,631			$	61,700			$	5,254,331
International Rest of World
Instruments		$	781,019			$	-			$	781,019			$	868,169			$	39,000			$	907,169
Handpieces			2,867,180				14,000				2,881,180				2,423,507				3,920				2,427,427
Other			32,568				-				32,568				41,001				-				41,001
Grand Total		$	3,680,767			$	14,000			$	3,694,767			$	3,332,677			$	42,920			$	3,375,597
International China
Instruments		$	310,000			$	-			$	310,000			$	-			$	-			$	-
Handpieces			-				-				-				-				-				-
Other			-				-				-				-				-				-
Grand Total		$	310,000			$	-			$	310,000			$	-			$	-			$	-
Total Product Sales		$	8,790,732			$	183,250			$	8,973,982			$	8,525,308			$	104,620			$	8,629,928

 

Current Product Platform